SEC Form 4 · accession 0000899243-15-003285
EndoChoice Holdings, Inc. · GI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Gilreath
Officer — See Remarks · Director
Period of report
Aug 14, 2015
Accepted (ET)
Aug 17, 2015 · 7:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001623919
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per shareF1 | Aug 14, 2015 | A | 140,739 | $0.00 | A | 733,250 | D | |
| Common stock, par value $0.001 per share | holding | — | — | — | 74,755 | I | By Mark Gregory Gilreath Irrevocable Trust | |
| Common stock, par value $0.001 per share | holding | — | — | — | 12,243 | I | By Entrust Georgia, LLC for the benefit of Mark G. Gilreath |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F2 | $16.01 | Aug 14, 2015 | A | 140,739 | A | — | Aug 14, 2025 | Common Stock | 140,739 | 140,739 | D |
Explanation of responses
- F1Represents shares of restricted common stock, with 25% vesting on August 14, 2016 and 2.083% vesting on the 14th of each month, beginning September 14, 2016, for a period of 36 months thereafter.
- F225% vesting and exercisable on August 14, 2016 and 2.083% vesting and exercisable on the 14th of each month, beginning September 14, 2016, for a period of 36 months thereafter.
Remarks
President and Chief Executive Officer